glp-1 gout Drugs Could Raise the Risk of Weaker Bones and GLP-1 Drugs Linked with Bone
Description
1b) confirming previous reports of the presence of PPG cells in the OB 15,16

Whilst these medicines offer significant therapeutic benefits, some patients report experiencing an unpleasant taste in their mouth during treatmentoften described as metallic, bitter, or simply 'off'

We start with low doses and titrate slowly
Corinne at Legacy Physicians.
Diabetes Care 39 , 20262035 (2016)

If you are taking a GLP-1 medication and notice any of the following, contact CVR to schedule an evaluation: Vein disease is progressive, and it tends to worsen over time without treatment
